15353-j-veluchamy

2 Harmonized NK FACS panels to study NK cell phenotype and function | 61 30. Roederer, M. Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats. Cytometry 45 , 194-205, doi:10.1002/1097-0320(20011101)45:3<194::AID- CYTO1163 >3.0.CO ;2-C (2001). 31. Silva-Santos, B., Serre, K. & Norell, H. [gamma][delta] T cells in cancer. Nat Rev Immunol 15 , 683- 691, doi:10.1038/nri3904 (2015). 32. Lugli, E., Marcenaro, E. & Mavilio, D. NK Cell Subset Redistribution during the Course of Viral Infections. Frontiers in immunology 5 , 390, doi:10.3389/fimmu.2014.00390 (2014). 33. Romee, R. et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121 , 3599-3608, doi:10.1182/blood-2012-04-425397 (2013). 34. Veluchamy, J. P. et al. Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. PLoS ONE 11 , e0157830, doi:10.1371/journal. pone.0157830 (2016). 35. Morvan, M. G. & Lanier, L. L. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer 16 , 7-19, doi:10.1038/nrc.2015.5 (2016). 36. Alderson, K. & Sondel, P. Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity. J Biomed Biotechnol 2011 , 379123 (2011). 37. Cheng, M., Chen, Y., Xiao, W., Sun, R. & Tian, Z. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 10 , 230-252, doi:10.1038/cmi.2013.10 (2013). 38. Leong, J. W. et al. Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells. Biology of Blood and Marrow Transplantation 20 , 463-473, doi :http://dx.doi.org/10.1016/j. bbmt.2014.01.006 (2014). 39. Byrd, A., Hoffmann, S. C., Jarahian, M., Momburg, F. & Watzl, C. Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44. PLoS ONE 2 , doi:10.1371/journal. pone.0001339 (2007). 40. Boukouaci, W. et al. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3−CD56+ NK cells: Potential impact on chronic graft versus host disease. Human Immunology 74 , 1536-1541, doi :http://dx.doi.org/10.1016/j.humimm.2013.08.281 (2013). 41. Dolstra H, Roeven MWH, Spanholtz J, Hangalapura BN, Tordoir M, Maas F, et al. Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients. Clin Cancer Res. 2017 Aug 1;23(15):4107-4118. doi: 10.1158/1078-0432.CCR-16-2981.PubMed PMID: 28220124 42. Fogel, L. A., Yokoyama, W. M. & French, A. R. Natural killer cells in human autoimmune disorders. Arthritis research & therapy 15 , 216, doi:10.1186/ar4232 (2013). 43. Konjevic, G. et al. Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma. Journal of clinical pathology , doi:10.1136/jclinpath-2016-203614 (2016).